Hepatitis B Vaccines

by author Leonard G. Horowitz



During the 1990s, legislators in the USA and Canada enacted a "mandate" that infants be vaccinated against hepatitis B. Suddenly, 12-hour-old infants were subjected to a virtually useless and highly risky series of three injections.

As a public health professional who had personally trained more than 20,000 health care workers in Occupational Safety and Health Administration (OSHA) requirements between 1990 and 1995, including hefty hepatitis B blood-borne pathogen training, I considered this to be completely absurd. My assessment was soon echoed by Dr Martin Schecter, Canada’s leading AIDS epidemiologist at the University of British Columbia and co-chair of the XI International Conference on AIDS.

Our mutual concern stemmed from the fact that the hepatitis B virus is a blood-borne pathogen and is sexually transmitted. The only major risk group is intravenous drug users. Combined, unsafe sex and intravenous drugs account for approximately 96 per cent of all hepatitis B transmissions. The other four per cent are predominantly medical and public safety personnel who get splashed with blood or stuck with contaminated needles. Infants are nowhere on that risk list!

My analysis showed that the hepatitis B vaccine "mandate" made no medical or scientific sense. In fact, as time passed, I realized that this was a classic example of how public health was being used as a cover for conducting toxic warfare. For example, vaccine makers admitted that a full one-third of those vaccinated received no benefit whatsoever. Subsequent injections commonly failed to prompt immunity against hepatitis B as well. The "mandated" hepatitis B vaccine, unlike naturally induced immunity, wore off every seven to 10 years in healthy and immunocompetent adults, far faster in children, the elderly and immune-compromised persons. So seven to 10 years later the teen would have to be retested or just assumed to have lost this immunity, and therefore vaccinated again--not once but three more times! Each time delivered additional risks.

The above data failed to address the high-risk teenagers who, at a young age, begin to experiment with or routinely practise unsafe sex and drug use. No matter how much money was invested in promoting hepatitis B vaccine compliance as a public health practice among these high risk-takers, it would consistently fail. Of this I was certain, given my expertise in public health education from Harvard School of Public Health. In other words, this official "public health policy" was scientifically unsupportable, if not downright bogus.

All I needed to do in order to establish that this was not science-based but a political, economic and genocidal policy was to carefully examine the risks of hepatitis B vaccine side-effects listed on package inserts or in the Physician’s Desk Reference. In summary:

I projected the approximate number of adverse reactions to the hepatitis B vaccine and multiplied those percentages by the approximately 80 million infants, children and teenagers targeted for the hepatitis B vaccination in the United States alone. This analysis yielded, conservatively, approximately 250,000 youth over the course of about 10 years would be crippled, brain damaged or killed. That meant approximately 25,000 hepatitis B vaccine-injured young victims were produced annually.

I conducted this analysis and predicted this ensuing mortality and morbidity in 1997. In 1998, I was unfortunately proven correct. That year, France suspended its hepatitis B vaccine program for children, "faced with a potential health disaster," the Associated Press reported, "because of fears that the vaccine could cause neurological disorders, in particular multiple sclerosis." When the 1996 hepatitis B vaccine adverse reactions were compiled by the Association of American Physicians and Surgeons (AAPS) for their 1999 report, they tallied almost 25,000 people seriously harmed. An AAPS press release noted that there were 440 deaths, 7,726 emergency room visits and 2,549 hospital stays in 24, 772 reports. Again, this number did not include all of the injured, only those injuries reported, which only represented approximately 10 per cent of the total population injured. "About 10 per cent of the patients had not recovered from the adverse effects," the medical organizations revealed, and "recovery status was listed as unknown in 33 per cent" of reported cases.

This evidence prompted the AAPS to petition the Clinton administration to lift its "mandate" on 12-hour-old infant hepatitis B vaccines, and they succeeded after high rates of reactions/deaths began to be confirmed. The vaccine is still in production, however, and still being recommended by physicians and pushed by manufacturers Merck and SmithKline. Infants in the USA and Canada continue to receive the hep B vaccine.

Vaccine Risk Awareness Network:
PO Box 169
Winlaw, BC, V0G 2J0

Eagle Foundation:
154 Provencher Blvd
Winnipeg, MB, R2H 0G3

Association for Vaccine Damaged Children:
67 Shier Drive
Winnipeg, MB, R3R 2H2

Source: Excerpted with permission from Death in the Air: Globalism, Terrorism and Toxic Warfare by Dr Leonard G. Horowitz.


Source: alive #229, November 2001